Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8950546 | Das Neurophysiologie-Labor | 2018 | 20 Pages |
Abstract
Stereotactic devices for surgical interventions on the brain were first described in 1947. Since 1987 deep brain stimulation was developed and replaced the lesional stereotactic interventions used before. Today deep brain stimulation devices have a CE- license for treatment of Parkinson's disease, tremor, dystonia, obsessive-compulsive disorders and epilepsy in Germany. Most patients with a deep brain stimulation suffer from Parkinson's disease. This articles outlines the current state of deep brain stimulation regarding indications, target point determination, intraoperative monitoring and postoperative patient care in the treatment of movement disorders.
Keywords
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Robert Pfister,